T-knife Launches Phase 1 Trial of CRISPR T Cell Therapy - Poll - MDSpire

T-knife Launches Phase 1 Trial of CRISPR T Cell Therapy

The first-in-human ATLAS trial will test PRAME-targeting CRISPR T cells in advanced cancers

  • March 16, 2026

  • 2 min

Share

Original Source(s)

T-knife Launches Phase 1 Trial of CRISPR T Cell Therapy

  • March 16, 2026

Related Content

Viable CAR T-cells remain detectable in cerebrospinal fluid in patients with grade ≥3 ICANS despite corticosteroid therapy

BCOR-CCNB3 fusion–positive sarcoma treated with chemotherapy and carbon-ion radiotherapy: a case report of long-term disease control of a cervical spine case with a 12-year follow-up

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes